These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4035664)

  • 1. Percutaneous absorption in man: a kinetic approach.
    Guy RH; Hadgraft J; Maibach HI
    Toxicol Appl Pharmacol; 1985 Mar; 78(1):123-9. PubMed ID: 4035664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of drug disposition kinetics in skin and plasma following topical administration.
    Guy RH; Hadgraft J
    J Pharm Sci; 1984 Jul; 73(7):883-7. PubMed ID: 6470948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous penetration of nicotinates: in vivo and in vitro measurements.
    Guy RH; Carlström EM; Bucks DA; Hinz RS; Maibach HI
    J Pharm Sci; 1986 Oct; 75(10):968-72. PubMed ID: 3795027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do partition coefficients (liphophilicity/hydrophilicity) predict effects of occlusion on percutaneous penetration in vitro: a retrospective review.
    Hafeez F; Maibach H
    Cutan Ocul Toxicol; 2013 Oct; 32(4):299-303. PubMed ID: 23535019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico prediction of percutaneous absorption and disposition kinetics of chemicals.
    Chen L; Han L; Saib O; Lian G
    Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does epidermal turnover reduce percutaneous penetration?
    Reddy MB; Guy RH; Bunge AL
    Pharm Res; 2000 Nov; 17(11):1414-9. PubMed ID: 11205736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.
    Nielsen JB; Nielsen F; Sørensen JA
    Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transport in relation to stratum corneum structure and lipid composition.
    Elias PM; Cooper ER; Korc A; Brown BE
    J Invest Dermatol; 1981 Apr; 76(4):297-301. PubMed ID: 7205031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vehicle effects on human stratum corneum absorption and skin penetration.
    Zhang A; Jung EC; Zhu H; Zou Y; Hui X; Maibach H
    Toxicol Ind Health; 2017 May; 33(5):416-425. PubMed ID: 27436841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning.
    Rougier A; Rallis M; Krien P; Lotte C
    Arch Dermatol Res; 1990; 282(8):498-505. PubMed ID: 2128017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling.
    Parry GE; Bunge AL; Silcox GD; Pershing LK; Pershing DW
    Pharm Res; 1990 Mar; 7(3):230-6. PubMed ID: 2339094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion modelling of percutaneous absorption kinetics. Predicting urinary excretion from in vitro skin permeation tests (IVPT) for an infinite dose.
    Liu X; Yousef S; Anissimov YG; van der Hoek J; Tsakalozou E; Ni Z; Grice JE; Roberts MS
    Eur J Pharm Biopharm; 2020 Apr; 149():30-44. PubMed ID: 32018051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of physicochemical properties of cyclic terpenes on their ex vivo skin absorption and elimination kinetics.
    Cal K; Kupiec K; Sznitowska M
    J Dermatol Sci; 2006 Feb; 41(2):137-42. PubMed ID: 16260121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin.
    Frasch HF; Barbero AM; Hettick JM; Nitsche JM
    J Pharm Sci; 2011 Jul; 100(7):2989-95. PubMed ID: 21283983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers.
    Cross SE; Magnusson BM; Winckle G; Anissimov Y; Roberts MS
    J Invest Dermatol; 2003 May; 120(5):759-64. PubMed ID: 12713577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occlusion effect on in vivo percutaneous penetration of chemicals in man and monkey: partition coefficient effects.
    Hafeez F; Maibach H
    Skin Pharmacol Physiol; 2013; 26(2):85-91. PubMed ID: 23327987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical aspects of percutaneous penetration and its enhancement.
    Guy RH; Hadgraft J
    Pharm Res; 1988 Dec; 5(12):753-8. PubMed ID: 3247284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.